PMID: 193113Apr 1, 1977

Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets

Proceedings of the National Academy of Sciences of the United States of America
P NeedlemanM S Minkes

Abstract

Human platelet suspensions release a rabbit-aorta-contracting substance (previously identified as thromboxane A2) during aggregation produced by arachidonic acid, prostaglandin endoperoxide, thrombin, and collagen. Incubation of platelets with imidazole did not interfere with the aggregation produced by these agonists but markedly reduced the generation of the rabbit-aorta-contracting substance. We find that imidazole inhibited the conversion of exogenous or endogenous prostaglandin endoperoxide into thromboxane A2-Imidazole selectively inhibits thromboxane synthetase in intact human platelets, because this agent blocks the conversion of [14C]arachidonate into [14C]thromboxane B2 but does not inhibit the conversion of [14C]arachidonate into [14C]prostaglandin E2. The inhibition of thromboxane synthetase by imidazole is not the result of an alteration in platelet 3':5'-cyclic AMP levels. These results illustrate the utility of imidazole as a pharmacological tool and demonstrate the two unique and dissociable properties of the endoperoxides themselves--their ability to aggregate platelets and their enzymatic conversion to the potent vasoconstrictor thromboxane.

References

Jan 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·P C IsaksonP Needleman
Sep 2, 1976·The New England Journal of Medicine·W F FriedmanS E Kirkpatrick
Jun 7, 1976·Biochemical and Biophysical Research Communications·L S WolfeJ Marion
Sep 2, 1976·The New England Journal of Medicine·M A HeymannN H Silverman
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Apr 14, 1976·Journal of the American Chemical Society·Cecil R Pace-Asciak
Apr 29, 1969·Biochemical and Biophysical Research Communications·S M Wolfe, N R Shulman
Mar 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·M Hamberg, B Samuelsson
Feb 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Dec 20, 1973·Biochimica Et Biophysica Acta·D H Nugteren, E Hazelhof
Jul 1, 1972·British Journal of Pharmacology·A Eckenfels, J R Vane

Citations

Oct 1, 1983·Journal of Clinical Immunology·J S Goodwin, J Ceuppens
Feb 1, 1988·Inflammation·P J SpagnuoloM J Dunn
Jan 1, 1989·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·G KehrerH J Bretschneider
Dec 22, 1978·Biochimica Et Biophysica Acta·H H Tai, B Yuan
Sep 12, 1979·Biochemical and Biophysical Research Communications·A M SieglM J Silver
Mar 1, 1983·Biochemical Pharmacology·F De Clerck, J M Van Nueten
Mar 1, 1979·European Journal of Pharmacology·K M MullaneJ R Vane
Dec 20, 1979·European Journal of Pharmacology·A V PrancanB B Vargaftig
May 7, 1982·European Journal of Pharmacology·R GreenbergT Steinbacher
Nov 11, 1983·European Journal of Pharmacology·E F SmithK Schrör
Jul 15, 1983·European Journal of Pharmacology·J NaitoM Tsuboshima
Oct 15, 1984·European Journal of Pharmacology·M J SheaB R Lucchesi
Oct 1, 1984·European Journal of Pharmacology·U Lerner, G Granström
Jul 1, 1980·Journal of Molecular and Cellular Cardiology·G G AhumadaP Needleman
Apr 1, 1978·Prostaglandins·J E Vincent, F J Zijlstra
Jan 1, 1981·Pharmacology & Therapeutics·J M Sullivan
Jan 1, 1995·Pharmacology & Therapeutics·H Vanden BosscheH Moereels
Dec 1, 1984·Prostaglandins, Leukotrienes, and Medicine·I MahmudH Brandenberger
Jan 1, 1978·Neuroscience Letters·A I AllyM Karmazyn
Sep 28, 1994·Biochimica Et Biophysica Acta·C C WuC M Teng
Dec 1, 1986·Journal of the American College of Cardiology·L A Harker, V Fuster
Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·E G LapetinaP Cuatrecasas
Feb 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P NeedlemanH Sprecher
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·G C Le BretonP V Halushka
Nov 15, 1994·Annals of the New York Academy of Sciences·W C PickettL Torley
Apr 19, 1986·British Medical Journal·I A ReillyG A FitzGerald
Feb 1, 1979·The Journal of Clinical Investigation·P NeedlemanA Raz
Sep 1, 1980·The Journal of Clinical Investigation·P J SpagnuoloM J Dunn
Oct 1, 1983·The Journal of Clinical Investigation·G A FitzGeraldA K Pedersen
Nov 1, 1988·The Journal of Clinical Investigation·D J FitzgeraldG A FitzGerald
Jan 1, 1981·Progress in Lipid Research·D E MacIntyre, E W Salzman
May 14, 1981·Biochimica Et Biophysica Acta·D F ReingoldP Needleman
Jun 8, 1984·Journal of Chromatography·P CremonesiG Sportoletti
Jan 1, 1982·International Journal of Immunopharmacology·A M Magro
Nov 14, 1979·Biochemical and Biophysical Research Communications·Z I TerashitaT Hino
Oct 30, 1978·Biochemical and Biophysical Research Communications·J E GreenwaldR V Panganamala
Nov 1, 1979·Biochemical Pharmacology·J M BoeynaemsJ E Dumont
Jun 15, 1984·Biochemical and Biophysical Research Communications·E R McCluskeyP Needleman
Sep 15, 1981·Thrombosis Research·R H HarrisP W Ramwell
Mar 1, 1987·Progress in Cardiovascular Diseases·V FusterJ H Chesebro
Dec 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S I Myers, L Bartula
Sep 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·G Di Benedetto
Jul 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·D M VaughnJ L Milton
Apr 1, 1988·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J M YanniM H Foxwell
Jun 1, 1983·Thrombosis Research·J P Rybicki, G C Le Breton
Sep 1, 1991·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S I MyersM K Reed
Jan 13, 1978·Biochemical and Biophysical Research Communications·H H Tai, B Yuan
Oct 1, 1984·The Journal of Surgical Research·R A PrinzJ Wallenga
Aug 1, 1985·The Journal of Surgical Research·L C CaseyP W Ramwell
Mar 1, 1982·Clinical and Experimental Pharmacology & Physiology·B R Creese, M A Denborough
Nov 7, 1977·Biochemical and Biophysical Research Communications·R R GormanO V Miller
Nov 21, 1977·Biochemical and Biophysical Research Communications·T V ZenserB B Davis
Jan 1, 1980·CRC Critical Reviews in Biochemistry·R J Gryglewski
May 1, 1995·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·E K LeGrandG S Dizerega
Aug 26, 1999·Human & Experimental Toxicology·K NakamuraK Yamada
Oct 1, 1977·FEBS Letters·U D Alusy, S Hammarström
Feb 1, 1986·Circulation·J M Ritter, C T Dollery
May 1, 1986·Stroke; a Journal of Cerebral Circulation·S KaplanM Walker
Aug 1, 1978·Circulation Research·W I Rosenblum, F El-Sabban
Nov 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S I Myers, L Bartula
Sep 1, 1980·Journal of Microsurgery·W H Chang, J J Petry
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Cecil R Pace-AsciakAndrea Sun
Jan 1, 1980·British Journal of Pharmacology·G AllanR Levi
May 1, 1992·Pacing and Clinical Electrophysiology : PACE·Y T TaiJ P Li
Jan 1, 1979·Scandinavian Journal of Haematology. Supplementum·A Kirstein
Jul 1, 1983·Scandinavian Journal of Haematology·M A HortonR J Jones
May 1, 1980·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·T T JungJ M Gerrard
Apr 1, 1983·The Journal of Pharmacy and Pharmacology·S Franchi-MicheliL Zilletti
Mar 1, 1997·The Journal of International Medical Research·H KatoI Saito
May 1, 1980·The Annals of Otology, Rhinology & Laryngology. Supplement·T T JungJ M Gerrard
Jan 1, 1981·Acta Medica Scandinavica. Supplementum·J B Smith

Related Concepts

Cyclic AMP, (R)-Isomer
Blood Platelets
Imidazoles
Oxidase
Platelet Aggregation

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.